A Multicenter, Randomized, Double-blind, 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC).
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
GILEAD SCIENCES S.L.U
Cita
A Multicenter, Randomized, Double-blind, 2-Part Phase 2 Study to Evaluate the Efficacy and Safety of GS-1427 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC). (GS-US-409-5704). GILEAD SCIENCES S.L.U. 2024-2025. IP:MARISA IBORRA COLOMINO.
Portal de investigación